vs
IBEX Ltd（IBEX）与PROCEPT BioRobotics Corp（PRCT）财务数据对比。点击上方公司名可切换其他公司
IBEX Ltd的季度营收约是PROCEPT BioRobotics Corp的2.0倍（$164.2M vs $83.1M），IBEX Ltd净利率更高（7.4% vs -38.1%，领先45.5%），PROCEPT BioRobotics Corp同比增速更快（20.2% vs 16.7%），过去两年PROCEPT BioRobotics Corp的营收复合增速更高（24.8% vs 13.8%）
IBEX 35是西班牙主要交易所马德里证券交易所的基准股票指数，该指数始创于1992年，由西班牙证券市场集团BME旗下的交易所公司负责计算与管理。它以市值加权编制，涵盖马德里证券交易所流动性最高的35只西班牙股票，每年进行两次成分股调整。
PROCEPT BioRobotics是一家专注于研发和商业化泌尿外科手术机器人解决方案的医疗科技企业，其旗舰AquaBeam系统可为良性前列腺增生患者提供图像引导微创治疗，服务覆盖北美、欧洲等地区的医疗机构与患者。
IBEX vs PRCT — 直观对比
营收规模更大
IBEX
是对方的2.0倍
$83.1M
营收增速更快
PRCT
高出3.5%
16.7%
净利率更高
IBEX
高出45.5%
-38.1%
两年增速更快
PRCT
近两年复合增速
13.8%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $164.2M | $83.1M |
| 净利润 | $12.2M | $-31.6M |
| 毛利率 | — | 64.9% |
| 营业利润率 | 9.3% | -4.1% |
| 净利率 | 7.4% | -38.1% |
| 营收同比 | 16.7% | 20.2% |
| 净利润同比 | 31.8% | -27.9% |
| 每股收益（稀释后） | $0.83 | $-0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IBEXPRCT
| Q1 26 | — | $83.1M | ||
| Q4 25 | $164.2M | $76.4M | ||
| Q3 25 | $151.2M | $83.3M | ||
| Q2 25 | $147.1M | $79.2M | ||
| Q1 25 | $140.7M | $69.2M | ||
| Q4 24 | $140.7M | $68.2M | ||
| Q3 24 | $129.7M | $58.4M | ||
| Q2 24 | $124.5M | $53.4M |
净利润IBEXPRCT
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $12.2M | $-29.8M | ||
| Q3 25 | $12.0M | $-21.4M | ||
| Q2 25 | $9.6M | $-19.6M | ||
| Q1 25 | $10.5M | $-24.7M | ||
| Q4 24 | $9.3M | $-18.9M | ||
| Q3 24 | $7.5M | $-21.0M | ||
| Q2 24 | $9.8M | $-25.6M |
毛利率IBEXPRCT
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
营业利润率IBEXPRCT
| Q1 26 | — | -4.1% | ||
| Q4 25 | 9.3% | -40.6% | ||
| Q3 25 | 9.1% | -27.8% | ||
| Q2 25 | 8.3% | -28.0% | ||
| Q1 25 | 9.5% | -39.7% | ||
| Q4 24 | 8.5% | -28.9% | ||
| Q3 24 | 7.0% | -38.4% | ||
| Q2 24 | 10.3% | -50.3% |
净利率IBEXPRCT
| Q1 26 | — | -38.1% | ||
| Q4 25 | 7.4% | -39.1% | ||
| Q3 25 | 8.0% | -25.7% | ||
| Q2 25 | 6.5% | -24.7% | ||
| Q1 25 | 7.4% | -35.8% | ||
| Q4 24 | 6.6% | -27.6% | ||
| Q3 24 | 5.8% | -35.9% | ||
| Q2 24 | 7.9% | -48.0% |
每股收益（稀释后）IBEXPRCT
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.83 | $-0.54 | ||
| Q3 25 | $0.82 | $-0.38 | ||
| Q2 25 | $0.63 | $-0.35 | ||
| Q1 25 | $0.73 | $-0.45 | ||
| Q4 24 | $0.57 | $-0.34 | ||
| Q3 24 | $0.43 | $-0.40 | ||
| Q2 24 | $0.55 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.5M | $245.6M |
| 总债务越低越好 | $594.0K | $51.7M |
| 股东权益账面价值 | $154.5M | $347.7M |
| 总资产 | $295.8M | $487.1M |
| 负债/权益比越低杠杆越低 | 0.00× | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资IBEXPRCT
| Q1 26 | — | $245.6M | ||
| Q4 25 | $15.5M | $286.5M | ||
| Q3 25 | $22.7M | $294.3M | ||
| Q2 25 | $15.3M | $302.7M | ||
| Q1 25 | $13.0M | $316.2M | ||
| Q4 24 | $20.2M | $333.7M | ||
| Q3 24 | $62.3M | $196.8M | ||
| Q2 24 | $62.7M | $214.1M |
总债务IBEXPRCT
| Q1 26 | — | $51.7M | ||
| Q4 25 | $594.0K | $51.6M | ||
| Q3 25 | $726.0K | $51.6M | ||
| Q2 25 | $796.0K | $51.5M | ||
| Q1 25 | $735.0K | $51.5M | ||
| Q4 24 | $695.0K | $51.5M | ||
| Q3 24 | $802.0K | $51.4M | ||
| Q2 24 | $867.0K | $51.4M |
股东权益IBEXPRCT
| Q1 26 | — | $347.7M | ||
| Q4 25 | $154.5M | $365.9M | ||
| Q3 25 | $143.6M | $380.3M | ||
| Q2 25 | $134.3M | $385.8M | ||
| Q1 25 | $124.2M | $389.2M | ||
| Q4 24 | $108.9M | $402.2M | ||
| Q3 24 | $171.1M | $241.2M | ||
| Q2 24 | $165.8M | $251.8M |
总资产IBEXPRCT
| Q1 26 | — | $487.1M | ||
| Q4 25 | $295.8M | $508.1M | ||
| Q3 25 | $283.9M | $511.5M | ||
| Q2 25 | $273.2M | $513.1M | ||
| Q1 25 | $274.7M | $519.4M | ||
| Q4 24 | $272.5M | $534.0M | ||
| Q3 24 | $306.3M | $374.1M | ||
| Q2 24 | $293.9M | $374.4M |
负债/权益比IBEXPRCT
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.00× | 0.14× | ||
| Q3 25 | 0.01× | 0.14× | ||
| Q2 25 | 0.01× | 0.13× | ||
| Q1 25 | 0.01× | 0.13× | ||
| Q4 24 | 0.01× | 0.13× | ||
| Q3 24 | 0.00× | 0.21× | ||
| Q2 24 | 0.01× | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.6M | — |
| 自由现金流经营现金流 - 资本支出 | $-5.1M | — |
| 自由现金流率自由现金流/营收 | -3.1% | — |
| 资本支出强度资本支出/营收 | 7.1% | — |
| 现金转化率经营现金流/净利润 | 0.54× | — |
| 过去12个月自由现金流最近4个季度 | $29.3M | — |
8季度趋势，按日历期对齐
经营现金流IBEXPRCT
| Q1 26 | — | — | ||
| Q4 25 | $6.6M | $-10.3M | ||
| Q3 25 | $15.7M | $-6.6M | ||
| Q2 25 | $27.9M | $-15.0M | ||
| Q1 25 | $8.8M | $-17.0M | ||
| Q4 24 | $1.1M | $-32.4M | ||
| Q3 24 | $7.8M | $-18.8M | ||
| Q2 24 | $17.4M | $-15.7M |
自由现金流IBEXPRCT
| Q1 26 | — | — | ||
| Q4 25 | $-5.1M | $-12.2M | ||
| Q3 25 | $8.0M | $-9.5M | ||
| Q2 25 | $22.8M | $-17.8M | ||
| Q1 25 | $3.6M | $-18.8M | ||
| Q4 24 | $-3.2M | $-33.6M | ||
| Q3 24 | $4.1M | $-19.0M | ||
| Q2 24 | $15.2M | $-16.8M |
自由现金流率IBEXPRCT
| Q1 26 | — | — | ||
| Q4 25 | -3.1% | -15.9% | ||
| Q3 25 | 5.3% | -11.4% | ||
| Q2 25 | 15.5% | -22.5% | ||
| Q1 25 | 2.5% | -27.2% | ||
| Q4 24 | -2.3% | -49.2% | ||
| Q3 24 | 3.2% | -32.6% | ||
| Q2 24 | 12.2% | -31.4% |
资本支出强度IBEXPRCT
| Q1 26 | — | — | ||
| Q4 25 | 7.1% | 2.4% | ||
| Q3 25 | 5.1% | 3.4% | ||
| Q2 25 | 3.5% | 3.5% | ||
| Q1 25 | 3.7% | 2.7% | ||
| Q4 24 | 3.1% | 1.7% | ||
| Q3 24 | 2.8% | 0.4% | ||
| Q2 24 | 1.8% | 2.0% |
现金转化率IBEXPRCT
| Q1 26 | — | — | ||
| Q4 25 | 0.54× | — | ||
| Q3 25 | 1.30× | — | ||
| Q2 25 | 2.91× | — | ||
| Q1 25 | 0.84× | — | ||
| Q4 24 | 0.12× | — | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | 1.77× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IBEX
| Transferred Over Time | $147.1M | 90% |
| Transferred At Point In Time | $17.1M | 10% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
